Stay updated on Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page.

Latest updates to the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page
- Check6 days agoChange DetectedThe record now shows that recruitment has ended, and the history reflects a new revision (v3.6.0) replacing the previous version (v3.5.5).SummaryDifference0.2%

- Check14 days agoChange DetectedThe history now includes a new revision entry labeled v3.5.5, replacing the earlier v3.5.4. This reflects a minor site revision reflected in the record history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page history now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This marks a new version of the page record on ClinicalTrials.gov.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page revision/build number was updated (v3.5.2 → v3.5.3), reflecting a site/version change rather than a change to the clinical trial record details.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the page history.SummaryDifference0.1%

- Check92 days agoChange DetectedNew revision v3.5.0 added to the Record History; revision v3.4.3 removed.SummaryDifference0.1%

Stay in the know with updates to Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page.